Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹1,779 Cr₹1,905 Cr₹1,525 Cr₹1,326 Cr₹1,698 Cr

What is the latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,779 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹1,779 Cr
Mar2025₹1,905 Cr
Mar2024₹1,525 Cr
Mar2023₹1,326 Cr
Mar2022₹1,698 Cr

How is Total Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2026 ₹1,779 Cr
-6.62
Mar2025 ₹1,905 Cr
24.93
Mar2024 ₹1,525 Cr
14.97
Mar2023 ₹1,326 Cr
-21.91
Mar2022 ₹1,698 Cr -

Compare Total Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,771.0 Cr -0.1% -4.1% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,831.0 Cr 2% 6% -6.7% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-0.1%

-4.1%

-4.7%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses